{"id":"retinol","rwe":[{"pmid":"41904900","year":"2026","title":"Unveiling Colorectal Cancer Cell Heterogeneity: Identification of Biomarkers and Disease-driving Cell Subpopulations through Scissor and CIBERSORTx on Integrated Transcriptomic Profiling.","finding":"","journal":"Computational biology and chemistry","studyType":"Clinical Study"},{"pmid":"41904678","year":"2026","title":"Loss of function of retinol dehydrogenase 11 causes a recessive syndrome characterized by myopathy, retinal dystrophy, juvenile cataracts, and microcephaly.","finding":"","journal":"Genetics in medicine : official journal of the American College of Medical Genetics","studyType":"Clinical Study"},{"pmid":"41901225","year":"2026","title":"Rosemary Aqueous Extract as a Natural Alternative to Retinol for Skin Aging Intervention.","finding":"","journal":"Pharmaceuticals (Basel, Switzerland)","studyType":"Clinical Study"},{"pmid":"41889417","year":"2026","title":"Riboflavin (VB2) inhibits hepatocellular carcinogenesis by enhancing retinol metabolism and suppressing cell proliferation in Hras12V transgenic mice.","finding":"","journal":"Frontiers in oncology","studyType":"Clinical Study"},{"pmid":"41881058","year":"2026","title":"Association of Salivary Asprosin and RBP4 Levels in Periodontitis Patients with Varying Waist-to-Height Ratios: A Case-Control Study.","finding":"","journal":"European journal of dentistry","studyType":"Clinical Study"}],"_fda":{"id":"11e7851d-314f-f32b-e063-6394a90ae02d","set_id":"03897ab7-fab1-fe83-e063-6294a90a8aa3","openfda":{"unii":["UCN889409V"],"route":["TOPICAL"],"spl_id":["11e7851d-314f-f32b-e063-6394a90ae02d"],"brand_name":["Dove"],"spl_set_id":["03897ab7-fab1-fe83-e063-6294a90a8aa3"],"package_ndc":["64942-2149-1"],"product_ndc":["64942-2149"],"generic_name":["MANUKA HONEY AND RETINOL SMOOTHING 48H ANTIPERSPIRANT DEODORANT"],"product_type":["HUMAN OTC DRUG"],"substance_name":["ALUMINUM SESQUICHLOROHYDRATE"],"manufacturer_name":["Conopco Inc. d/b/a/ Unilever"],"application_number":["M019"],"is_original_packager":[true]},"purpose":["Purpose antiperspirant"],"version":"2","warnings":["Warnings • For external use only. • Do not use on broken skin . • Ask a doctor before use if you have kidney disease. • Stop use if rash or irritation occurs."],"questions":["Questions? Call 1-800-761-3683"],"description":["SHEA MOISTURE MANUKA HONEY & RETINOL 48H ANTIPERSPIRANT DEODORANT - aluminum sesquichlorohydrate stick"],"effective_time":"20240221","active_ingredient":["Drug Facts Active ingredient Aluminum Sesquichlorohydrate (12.2)"],"inactive_ingredient":["Inactive ingredients Water (Aqua), C12-15 Alkyl Benzoate, Cyclopentasiloxane, Synthetic Wax, Glycerin, Calcium Chloride, Cetyl PEG/PPG-10/1 Dimethicone, Glycine, Fragrance (Parfum), Helianthus Annuus (Sunflower) Seed Oil, Butyrospermum Parkii (Shea) Butter, Honey, Retinol, Benzyl Alcohol, Benzyl Cinnamate, Benzyl Salicylate, Citronellol, Coumarin, Farnesol, Hexyl Cinnamal, Limonene, Linalool."],"indications_and_usage":["Uses reduces underarm wetness"],"dosage_and_administration":["Directions apply to underarms only"],"spl_product_data_elements":["Dove Manuka Honey and Retinol Smoothing 48h Antiperspirant Deodorant LINALOOL, (+/-)- SUNFLOWER OIL BENZYL CINNAMATE .BETA.-CITRONELLOL, (R)- LIMONENE, (+)- CYCLOMETHICONE 5 CALCIUM CHLORIDE WATER ALKYL (C12-15) BENZOATE SYNTHETIC WAX (1200 MW) ALUMINUM SESQUICHLOROHYDRATE ALUMINUM SESQUICHLOROHYDRATE GLYCERIN CETYL PEG/PPG-10/1 DIMETHICONE (HLB 4) GLYCINE RETINOL SHEA BUTTER BENZYL ALCOHOL HONEY COUMARIN BENZYL SALICYLATE FARNESOL .ALPHA.-HEXYLCINNAMALDEHYDE"],"keep_out_of_reach_of_children":["• Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away."],"package_label_principal_display_panel":["Packaging Shea Moisture Smoothing AP Deo"]},"tags":[{"label":"Vitamin A","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Amyloid beta A4 protein","category":"target"},{"label":"APP","category":"gene"},{"label":"RBP4","category":"gene"},{"label":"SNCA","category":"gene"},{"label":"A11CA01","category":"atc"},{"label":"Oral","category":"route"},{"label":"Topical","category":"route"},{"label":"Capsule","category":"form"},{"label":"Cloth","category":"form"},{"label":"Cream","category":"form"},{"label":"Patch","category":"form"},{"label":"Active","category":"status"},{"label":"Mineral Deficiency Prevention","category":"indication"},{"label":"Mineral deficiency","category":"indication"},{"label":"Prevention of dental caries","category":"indication"},{"label":"Vitamin A deficiency","category":"indication"},{"label":"Vitamin Deficiency Prevention","category":"indication"},{"label":"Vitamin deficiency","category":"indication"},{"label":"Hospira","category":"company"},{"label":"Approved 1950s","category":"decade"},{"label":"Micronutrients","category":"pharmacology"},{"label":"Vitamins","category":"pharmacology"}],"phase":"marketed","safety":{"boxedWarnings":[],"safetySignals":[{"date":"","signal":"APPLICATION SITE PAIN","source":"FDA FAERS","actionTaken":"3 reports"},{"date":"","signal":"ACNE","source":"FDA FAERS","actionTaken":"1 reports"},{"date":"","signal":"APPLICATION SITE ERYTHEMA","source":"FDA FAERS","actionTaken":"1 reports"},{"date":"","signal":"APPLICATION SITE IRRITATION","source":"FDA FAERS","actionTaken":"1 reports"},{"date":"","signal":"APPLICATION SITE RASH","source":"FDA FAERS","actionTaken":"1 reports"},{"date":"","signal":"DRUG INEFFECTIVE","source":"FDA FAERS","actionTaken":"1 reports"},{"date":"","signal":"DRUG INEFFECTIVE FOR UNAPPROVED INDICATION","source":"FDA FAERS","actionTaken":"1 reports"},{"date":"","signal":"OFF LABEL USE","source":"FDA FAERS","actionTaken":"1 reports"},{"date":"","signal":"POOR QUALITY PRODUCT ADMINISTERED","source":"FDA FAERS","actionTaken":"1 reports"},{"date":"","signal":"PRODUCT PHYSICAL CONSISTENCY ISSUE","source":"FDA FAERS","actionTaken":"1 reports"}],"commonSideEffects":[],"contraindications":["Anemia due to enzyme deficiency","Arteriosclerosis obliterans","Disease of liver","Diverticular disease","Gastroenteritis","Hb SS disease","Hemochromatosis","Hemolytic anemia","Hemosiderosis","Hypercalcemia","Hyperphosphatemia","Hypervitaminosis A","Hypervitaminosis D","Kidney disease","Kidney stone","Malabsorption States","Peptic ulcer","Pregnancy, function","Primary hyperoxaluria","Repeated Blood Transfusions","Sarcoidosis","Ulcerative colitis"]},"trials":[],"aliases":[],"company":"Pfizer","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=RETINOL","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T03:30:23.807508+00:00"},"aiSummary":{"url":"","method":"ai_extraction","source":"AI Strategic Summary","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"ai_extraction","retrievedAt":"2026-04-20T03:30:45.365970+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T03:30:31.139347+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=RETINOL","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T03:30:31.781787+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T03:30:21.588869+00:00"},"indications.approved":{"url":"","method":"ai_extraction","source":"FDA Label + AI","aiModel":"featherless","rawText":"","confidence":0.9,"sourceType":"fda_label","retrievedAt":"2026-04-20T03:30:39.415392+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T03:30:21.588927+00:00"},"safety.safetySignals":{"url":"https://api.fda.gov/drug/event.json","method":"api_direct","source":"FDA FAERS","rawText":"","confidence":1,"sourceType":"fda_faers","retrievedAt":"2026-04-20T03:30:33.332632+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL986/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T03:30:32.265645+00:00"},"regulatory.fda_application":{"url":"","method":"deterministic","source":"FDA Label","rawText":"M019","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T03:30:21.588938+00:00"}},"allNames":"m.v.i. pediatric","offLabel":[],"synonyms":["vitamin A1","vitamin A","retinol","retinol (vit A)"],"timeline":[{"date":"1953-02-20","type":"positive","source":"DrugCentral","milestone":"FDA approval (Hospira)"}],"aiSummary":"M.V.I. Pediatric (RETINOL), marketed by Pfizer, is a vitamin A supplement primarily indicated to reduce underarm wetness, positioning it in a niche market segment. Its key strength lies in its essential role in maintaining skin, vision, and immune function, differentiating it from same-class competitors like betacarotene. The primary risk is the key composition patent expiry in 2028, which could lead to increased competition from generics.","approvals":[{"date":"1953-02-20","orphan":false,"company":"HOSPIRA","regulator":"FDA"}],"brandName":"M.V.I. Pediatric","ecosystem":[{"indication":"Mineral Deficiency Prevention","otherDrugs":[{"name":"ferrous sulfate","slug":"ferrous-sulfate","company":"Lederle"},{"name":"folic acid","slug":"folic-acid","company":"Lederle"},{"name":"riboflavin","slug":"riboflavin","company":"Hospira"},{"name":"thiamine","slug":"thiamine","company":"Hospira"}],"globalPrevalence":null},{"indication":"Mineral deficiency","otherDrugs":[{"name":"ferrous sulfate","slug":"ferrous-sulfate","company":"Lederle"},{"name":"folic acid","slug":"folic-acid","company":"Lederle"},{"name":"riboflavin","slug":"riboflavin","company":"Hospira"},{"name":"thiamine","slug":"thiamine","company":"Hospira"}],"globalPrevalence":null},{"indication":"Prevention of dental caries","otherDrugs":[{"name":"colecalciferol","slug":"colecalciferol","company":"Sandoz"},{"name":"ergocalciferol","slug":"ergocalciferol","company":"Sanofi Aventis Us"},{"name":"potassium nitrate","slug":"potassium-nitrate","company":""},{"name":"sodium fluoride","slug":"sodium-fluoride","company":"Colgate Palmolive"}],"globalPrevalence":null},{"indication":"Vitamin A deficiency","otherDrugs":[],"globalPrevalence":null},{"indication":"Vitamin Deficiency Prevention","otherDrugs":[{"name":"cyanocobalamin","slug":"cyanocobalamin","company":""},{"name":"ergocalciferol","slug":"ergocalciferol","company":"Sanofi Aventis Us"},{"name":"ferrous sulfate","slug":"ferrous-sulfate","company":"Lederle"},{"name":"folic acid","slug":"folic-acid","company":"Lederle"}],"globalPrevalence":null},{"indication":"Vitamin deficiency","otherDrugs":[{"name":"colecalciferol","slug":"colecalciferol","company":"Sandoz"},{"name":"cyanocobalamin","slug":"cyanocobalamin","company":""},{"name":"ergocalciferol","slug":"ergocalciferol","company":"Sanofi Aventis Us"},{"name":"ferrous sulfate","slug":"ferrous-sulfate","company":"Lederle"}],"globalPrevalence":null}],"mechanism":{"target":"Amyloid beta A4 protein","novelty":"First-in-class","targets":[{"gene":"APP","source":"DrugCentral","target":"Amyloid beta A4 protein","protein":"Amyloid beta A4 protein"},{"gene":"RBP4","source":"DrugCentral","target":"Retinol-binding protein 4","protein":"Retinol-binding protein 4"},{"gene":"SNCA","source":"DrugCentral","target":"Alpha-synuclein","protein":"Alpha-synuclein"},{"gene":"NR2C2","source":"DrugCentral","target":"Nuclear receptor subfamily 2 group C member 2","protein":"Nuclear receptor subfamily 2 group C member 2"},{"gene":"RDH5","source":"DrugCentral","target":"11-cis retinol dehydrogenase","protein":"11-cis retinol dehydrogenase"},{"gene":"ALDH1A1","source":"DrugCentral","target":"Retinal dehydrogenase 1","protein":"Retinal dehydrogenase 1"},{"gene":"ALDH1A2","source":"DrugCentral","target":"Retinal dehydrogenase 2","protein":"Retinal dehydrogenase 2"},{"gene":"RLBP1","source":"DrugCentral","target":"Retinaldehyde-binding protein 1","protein":"Retinaldehyde-binding protein 1"},{"gene":"RBP7","source":"DrugCentral","target":"Retinoid-binding protein 7","protein":"Retinoid-binding protein 7"},{"gene":"RDH12","source":"DrugCentral","target":"Retinol dehydrogenase 12","protein":"Retinol dehydrogenase 12"}],"modality":"Small Molecule","drugClass":"Vitamin A","explanation":"","oneSentence":"","technicalDetail":"M.V.I. Pediatric (RETINOL) acts as a small molecule agonist of retinoic acid receptors, which play a crucial role in regulating gene expression and cellular differentiation."},"commercial":{"launchDate":"1953","_launchSource":"DrugCentral (FDA 1953-02-20, HOSPIRA)"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/2831","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=RETINOL","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=RETINOL","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:34:51.743745","_validation":{"fieldsValidated":2,"lastValidatedAt":"2026-04-20T03:30:45.366487+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"betacarotene","drugSlug":"betacarotene","fdaApproval":"","relationship":"same-class"}],"genericName":"retinol","indications":{"approved":[{"id":"retinol-reduces-underarm-wetness","name":"Reduces underarm wetness","dosing":null,"approvals":[],"diseaseId":"","eligibility":"Not specified","pivotalTrial":null,"restrictions":[],"patientPopulation":"Not specified","diagnosticRequired":null,"brandNameForIndication":"M.V.I. Pediatric"}],"offLabel":[{"name":"Abetalipoproteinemia","source":"DrugCentral","drugName":"RETINOL","evidenceCount":46,"evidenceLevel":"moderate"},{"name":"Diaper rash","source":"DrugCentral","drugName":"RETINOL","evidenceCount":6,"evidenceLevel":"emerging"},{"name":"Skin irritation","source":"DrugCentral","drugName":"RETINOL","evidenceCount":329,"evidenceLevel":"strong"}],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"betacarotene","brandName":"betacarotene","genericName":"betacarotene","approvalYear":"","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT01711554","phase":"PHASE1","title":"Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2013-02-04","conditions":["Recurrent Neuroblastoma","Refractory Neuroblastoma"],"enrollment":27,"completionDate":"2027-03-03"},{"nctId":"NCT06172296","phase":"PHASE3","title":"Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-04-19","conditions":["Ganglioneuroblastoma, Nodular","Neuroblastoma"],"enrollment":478,"completionDate":"2029-12-31"},{"nctId":"NCT05601817","phase":"NA","title":"Virtual Reality and Computerized Cognitive Intervention for Mild Cognitive Impairment in Heart Failure","status":"ACTIVE_NOT_RECRUITING","sponsor":"Indiana University","startDate":"2023-04-03","conditions":["Heart Failure","Mild Cognitive Impairment"],"enrollment":172,"completionDate":"2027-03-31"},{"nctId":"NCT07356440","phase":"NA","title":"Effect of the Consumption of Cookies Enriched With Plant Proteins and of a Vitamin D Supplement on the Progression of Sarcopenia in the Elderly","status":"ENROLLING_BY_INVITATION","sponsor":"University of Udine","startDate":"2025-12-01","conditions":["Sarcopenia in Elderly","Sarcopenia","Nutritional Intervention","Microbiome Analysis","Muscle Mass and Strength","Biomarkers / Blood","Quality of Life Outcomes"],"enrollment":74,"completionDate":"2026-12"},{"nctId":"NCT05702398","phase":"EARLY_PHASE1","title":"Pilot Trial of Supplemental Vitamin A and Nicotinamide","status":"RECRUITING","sponsor":"Rhode Island Hospital","startDate":"2023-04-01","conditions":["Skin Cancer","Kidney Transplant Recipients"],"enrollment":30,"completionDate":"2028-03-01"},{"nctId":"NCT07477275","phase":"NA","title":"Combination of Oral and Topical Whitening Agents for Reducing Skin Pigmentation","status":"ACTIVE_NOT_RECRUITING","sponsor":"USMARI Research & Innovation Centre","startDate":"2024-12-01","conditions":["Dark Spots"],"enrollment":68,"completionDate":"2026-04-30"},{"nctId":"NCT04874688","phase":"NA","title":"Child Health, Agriculture and Integrated Nutrition","status":"COMPLETED","sponsor":"Queen Mary University of London","startDate":"2021-04-26","conditions":["Stunting"],"enrollment":192,"completionDate":"2022-02-18"},{"nctId":"NCT05372445","phase":"NA","title":"Microbiome and Health Indicators in People With Obesity, Prediabetes and Type 2 Diabetes Undergoing a Lifestyle Intervention","status":"TERMINATED","sponsor":"National Council of Scientific and Technical Research, Argentina","startDate":"2022-05-30","conditions":["Diabetes Mellitus, Type 2","Obesity","PreDiabetes"],"enrollment":468,"completionDate":"2025-07-31"},{"nctId":"NCT07469228","phase":"PHASE1","title":"A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO ® Gel Microsphere, 0.04% in the Treatment of Acne Vulgaris","status":"COMPLETED","sponsor":"Sun Pharmaceutical Industries, Inc.","startDate":"2025-08-04","conditions":["Acne Vulgaris"],"enrollment":1043,"completionDate":"2025-12-15"},{"nctId":"NCT07468175","phase":"NA","title":"A 16-week Clinical Study Investigating a Dark Spot Corrector Serum in Women With Moderate Discrete Hyperpigmentation","status":"COMPLETED","sponsor":"Revision Skincare","startDate":"2024-10-21","conditions":["Hyperpigmentation","Dark Spots"],"enrollment":48,"completionDate":"2025-03-27"},{"nctId":"NCT00026312","phase":"PHASE3","title":"Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2001-10-26","conditions":["Localized Resectable Neuroblastoma","Localized Unresectable Neuroblastoma","Recurrent Neuroblastoma","Regional Neuroblastoma","Stage 4 Neuroblastoma","Stage 4S Neuroblastoma"],"enrollment":1449,"completionDate":"2025-12-31"},{"nctId":"NCT06047379","phase":"PHASE1,PHASE2","title":"Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis","status":"RECRUITING","sponsor":"Neonc Technologies, Inc.","startDate":"2023-11-01","conditions":["Diffuse Astrocytoma, IDH-Mutant","Glioblastoma, IDH-wildtype","Brain Metastases, Adult","Cervical Cancer","Colorectal Cancer","Esophageal Cancer","Esophageal Squamous Cell Carcinoma","Gastric Cancer","Gastroesophageal Junction Adenocarcinoma","Head and Neck Squamous Cell Carcinoma","Melanoma","Merkel Cell Carcinoma","Microsatellite Instability-High Solid Malignant Tumor","Mismatch Repair Deficient Solid Malignant Tumor","Microsatellite Instability-High Colorectal Cancer","Mismatch Repair Deficient Colorectal Cancer","Non-small Cell Lung Cancer","Renal Cell Carcinoma","Small Cell Lung Cancer","Squamous Cell Carcinoma","Urothelial Carcinoma"],"enrollment":134,"completionDate":"2027-08-31"},{"nctId":"NCT03126916","phase":"PHASE3","title":"Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)","status":"RECRUITING","sponsor":"Children's Oncology Group","startDate":"2018-05-14","conditions":["Ganglioneuroblastoma","Ganglioneuroblastoma, Nodular","Neuroblastoma"],"enrollment":750,"completionDate":"2030-09-30"},{"nctId":"NCT05345002","phase":"PHASE2","title":"All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma","status":"RECRUITING","sponsor":"Stephen Bagley, MD, MSCE","startDate":"2022-11-16","conditions":["Glioma","IDH Mutation","Astrocytoma","Oligodendroglioma"],"enrollment":55,"completionDate":"2028-06-01"},{"nctId":"NCT02339740","phase":"PHASE3","title":"Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2015-07-21","conditions":["Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA"],"enrollment":158,"completionDate":"2029-06-30"},{"nctId":"NCT04919369","phase":"PHASE1","title":"All-Trans Retinoic Acid (ATRA) and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dwight Owen","startDate":"2021-10-18","conditions":["Metastatic Lung Non-Small Cell Carcinoma","Recurrent Lung Non-Small Cell Carcinoma","Stage IV Lung Cancer AJCC v8","Stage IVA Lung Cancer AJCC v8","Stage IVB Lung Cancer AJCC v8"],"enrollment":18,"completionDate":"2026-12-31"},{"nctId":"NCT06358677","phase":"PHASE2","title":"Topical Tretinoin Prophylaxis for Anti-EGFR Induced Skin Toxicity in Patients With Solid Tumors","status":"RECRUITING","sponsor":"University of Utah","startDate":"2025-02-19","conditions":["Metastatic Solid Tumor","Locally Advanced Solid Tumor"],"enrollment":25,"completionDate":"2029-07"},{"nctId":"NCT07407101","phase":"NA","title":"Impact of Filtration on Autologous Serum Eye Drops","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Limoges","startDate":"2026-04-30","conditions":["Dry Eye Syndrome (DES)"],"enrollment":10,"completionDate":"2027-04-29"},{"nctId":"NCT07401992","phase":"PHASE4","title":"Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis","status":"RECRUITING","sponsor":"Hospital Universitario Dr. Jose E. Gonzalez","startDate":"2026-01-15","conditions":["Psoriasis (PsO)","Obesity & Overweight","Diabetes Mellitus - Type 2"],"enrollment":62,"completionDate":"2027-02-28"},{"nctId":"NCT05085340","phase":"","title":"MULTIple Doses of IPTi Proposal: a Lifesaving High Yield Intervention","status":"COMPLETED","sponsor":"Barcelona Institute for Global Health","startDate":"2022-02-14","conditions":["Malaria"],"enrollment":94252,"completionDate":"2025-10-31"},{"nctId":"NCT05590468","phase":"PHASE2","title":"A Study to Evaluate Vitamin B3 Derivative to Treat Mitochondrial Myopathy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ralitza Gavrilova","startDate":"2023-05-26","conditions":["Mitochondrial Myopathy"],"enrollment":34,"completionDate":"2026-11"},{"nctId":"NCT01175356","phase":"PHASE1","title":"Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2011-12-21","conditions":["Ganglioneuroblastoma","Localized Resectable Neuroblastoma","Localized Unresectable Neuroblastoma","Regional Neuroblastoma","Stage 4 Neuroblastoma","Stage 4S Neuroblastoma"],"enrollment":99,"completionDate":"2025-12-31"},{"nctId":"NCT07364383","phase":"NA","title":"Probiotics for Women","status":"NOT_YET_RECRUITING","sponsor":"Cultech Ltd","startDate":"2026-01-09","conditions":["Probiotic","Microbiome","Wellbeing"],"enrollment":40,"completionDate":"2026-05-01"},{"nctId":"NCT07345507","phase":"NA","title":"Comparison of Efficacy of Metformin Gel 30% vs Triple Combination Cream (Hydroquinone 4%, Flucinolone Acetonide 0.01%, Tretinoin 0.025%) in Treatment of Melasma in Tertiary Care Hospital Karachi","status":"COMPLETED","sponsor":"Jinnah Postgraduate Medical Centre","startDate":"2025-02-01","conditions":["Melasma"],"enrollment":34,"completionDate":"2025-08-30"},{"nctId":"NCT07345754","phase":"NA","title":"Women Supporting Women to Improve Infant and Child Feeding Practices in Pakistan","status":"RECRUITING","sponsor":"University of British Columbia","startDate":"2025-10-01","conditions":["Malnutrition in Children"],"enrollment":200,"completionDate":"2027-12-31"},{"nctId":"NCT07348107","phase":"PHASE1","title":"ATRA and SDK002 in Combination With Chemotherapy and Anti-PD-1 Inhibitor in Patients With Advanced Pancreatic Ductal Adenocarcinoma.","status":"NOT_YET_RECRUITING","sponsor":"Daniel Breadner","startDate":"2026-02-15","conditions":["Advanced Pancreatic Ductal Adenocarcinoma"],"enrollment":10,"completionDate":"2027-03"},{"nctId":"NCT06596733","phase":"NA","title":"Vit-A-Vision® Clinical Investigation","status":"RECRUITING","sponsor":"OmniVision GmbH","startDate":"2025-12-19","conditions":["Burning Eye","Irritation; Eyeball","Tired Eye","Dry Eye Disease"],"enrollment":77,"completionDate":"2026-10-31"},{"nctId":"NCT06438562","phase":"NA","title":"Evaluation of Vitamin A Absorption From Fortified Bouillon","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2024-07-10","conditions":["Healthy Volunteers","Vitamin A"],"enrollment":58,"completionDate":"2025-12-08"},{"nctId":"NCT07341217","phase":"NA","title":"Chemo Brain Prehab Project","status":"NOT_YET_RECRUITING","sponsor":"Dr. Chris Gaffney","startDate":"2026-01-30","conditions":["Colorectal Cancer","Older Adults (60 - 85 Years Old)","Physically Inactive","Chemotherapy"],"enrollment":86,"completionDate":"2027-09-16"},{"nctId":"NCT07335991","phase":"NA","title":"Effect of Vitamin A Supplementation on Idiopathic Scoliosis","status":"RECRUITING","sponsor":"Second Affiliated Hospital of Wenzhou Medical University","startDate":"2025-05-13","conditions":["Vitamin A Deficiency","Idiopathic Scoliosis"],"enrollment":140,"completionDate":"2028-06-01"},{"nctId":"NCT04241276","phase":"PHASE2","title":"A Randomised Trial of ATRA in a Novel Drug Combination for Pancreatic Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Queen Mary University of London","startDate":"2020-04-30","conditions":["Pancreatic Cancer"],"enrollment":170,"completionDate":"2029-02-28"},{"nctId":"NCT07296445","phase":"PHASE3","title":"A Trial to Investigate Whether Oral Arsenic Trioxide Is Similar to Intravenous Arsenic Trioxide in Pharmacokinetics, Safety, and Efficacy (LATITUDE/SDKARS-301)","status":"NOT_YET_RECRUITING","sponsor":"SDK Therapeutics, Inc.","startDate":"2026-01","conditions":["Acute Promyelocytic Leukemia (APL)","Acute Promyelocytic Leukaemia","Acute Promyelocytic Leukemia With PML-RARA","Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA","APL","Acute Promyelocytic Leukemia","Leukaemia","Leukemia Acute Promyelocytic Leukemia (APL)","Leukemia, Acute"],"enrollment":120,"completionDate":"2029-01"},{"nctId":"NCT07296354","phase":"PHASE4","title":"Evaluation of an ATP-Containing Parenteral Vitamin B Complex in Patients With Symptomatic Diabetic Polyneuropathy","status":"NOT_YET_RECRUITING","sponsor":"Egyptian International Pharmaceutical Industries Co","startDate":"2026-01-10","conditions":["Neuropathic Pain"],"enrollment":200,"completionDate":"2029-01-10"},{"nctId":"NCT07296393","phase":"","title":"Vitamin A in Cord Blood and Preterm Outcomes","status":"NOT_YET_RECRUITING","sponsor":"The First Hospital of Jilin University","startDate":"2025-12-10","conditions":["Extremely Premature Infant"],"enrollment":155,"completionDate":"2027-12-30"},{"nctId":"NCT04113863","phase":"PHASE2","title":"Evaluation of ATRA Activity in Combination With Anastrozole in Pre-operative Phase of Operable Early Breast Cancer","status":"TERMINATED","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2019-06-18","conditions":["Breast Neoplasm Female"],"enrollment":76,"completionDate":"2025-01-30"},{"nctId":"NCT01409161","phase":"PHASE2","title":"Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2011-10-05","conditions":["Acute Promyelocytic Leukemia With PML-RARA"],"enrollment":151,"completionDate":"2027-12-18"},{"nctId":"NCT05323292","phase":"","title":"Vitamin A Status in Patients With Vocal Fold Leukoplakia","status":"ENROLLING_BY_INVITATION","sponsor":"University of Wisconsin, Madison","startDate":"2022-06-29","conditions":["Vitamin A","Vitamin A Deficiency","Leukoplakia","Vocal Cord Neoplasm"],"enrollment":90,"completionDate":"2026-12-31"},{"nctId":"NCT05646394","phase":"","title":"Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS","status":"RECRUITING","sponsor":"McMaster University","startDate":"2022-07-01","conditions":["Antiphospholipid Syndrome","Arterial Thrombosis"],"enrollment":150,"completionDate":"2029-12-31"},{"nctId":"NCT06397118","phase":"NA","title":"Prevention of Malnutrition in Children With Sickle Cell Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2024-11-06","conditions":["Sickle Cell Disease","Malnutrition"],"enrollment":148,"completionDate":"2027-05-31"},{"nctId":"NCT04499820","phase":"NA","title":"Effect of OMEGA3 Supplementation in Diabetic Retinopathy","status":"COMPLETED","sponsor":"Centre Hospitalier Intercommunal Creteil","startDate":"2020-06-26","conditions":["Diabetic Retinopathy"],"enrollment":60,"completionDate":"2025-04-17"},{"nctId":"NCT07257497","phase":"PHASE1","title":"Safety and Efficacy of Combining a Vitamin B6-Limited Diet With Immunotherapy in Solid Tumor Patients: A Clinical Study Protocol","status":"NOT_YET_RECRUITING","sponsor":"West China Hospital","startDate":"2025-12-09","conditions":["Solid Tumor Cancer"],"enrollment":20,"completionDate":"2027-06-01"},{"nctId":"NCT06439888","phase":"PHASE1,PHASE2","title":"Lymphocyte Support to SBRT in Patients With Oligo-metastatic Solid Cancer","status":"RECRUITING","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2024-07-11","conditions":["Oligometastatic Disease","Solid Tumor, Adult"],"enrollment":58,"completionDate":"2027-01"},{"nctId":"NCT06706401","phase":"PHASE3","title":"Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma","status":"RECRUITING","sponsor":"Centre Leon Berard","startDate":"2025-02-20","conditions":["Oropharynx Cancer","Larynx Cancer","Hypopharynx Cancer","Primary Head and Neck Tumor"],"enrollment":460,"completionDate":"2029-01"},{"nctId":"NCT06731140","phase":"PHASE2","title":"Reverse HER2-negative Immune Resistant Breast Cancer","status":"RECRUITING","sponsor":"Fudan University","startDate":"2025-02-12","conditions":["HER2 Negative Breast Cancer"],"enrollment":10,"completionDate":"2027-10"},{"nctId":"NCT02712905","phase":"PHASE1,PHASE2","title":"An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies","status":"TERMINATED","sponsor":"Incyte Corporation","startDate":"2016-05-05","conditions":["Solid Tumors and Hematologic Malignancy"],"enrollment":116,"completionDate":"2022-04-14"},{"nctId":"NCT03845582","phase":"PHASE2,PHASE3","title":"Phase 2/3 Study of ALK-001 in Geographic Atrophy","status":"COMPLETED","sponsor":"Alkeus Pharmaceuticals, Inc.","startDate":"2019-05-07","conditions":["Geographic Atrophy","Age Related Macular Degeneration","AMD","Atrophy, Geographic"],"enrollment":200,"completionDate":"2024-06-30"},{"nctId":"NCT04182763","phase":"NA","title":"CoA-Z in Pantothenate Kinase-associated Neurodegeneration (PKAN)","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2019-12-04","conditions":["Pantothenate Kinase-Associated Neurodegeneration"],"enrollment":77,"completionDate":"2025-01-01"},{"nctId":"NCT04385277","phase":"PHASE2","title":"Treatment With Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma (NBL)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2020-12-31","conditions":["Ganglioneuroblastoma, Nodular","Neuroblastoma"],"enrollment":41,"completionDate":"2027-09-30"},{"nctId":"NCT04303169","phase":"PHASE1,PHASE2","title":"Substudy 02C: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Stage III Melanoma Who Are Candidates for Neoadjuvant Therapy (MK-3475-02C/KEYMAKER-U02)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-06-26","conditions":["Melanoma"],"enrollment":146,"completionDate":"2025-09-24"},{"nctId":"NCT07151105","phase":"NA","title":"Anti-inflammatory Activities of Vitamin C Supplementation on the Gut Barrier Function in Adults With Obesity","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2025-10-01","conditions":["Adequate Vitamin C Status","Inadequate Vitamin C Status"],"enrollment":34,"completionDate":"2026-12-30"},{"nctId":"NCT03786783","phase":"PHASE2","title":"Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-03-04","conditions":["Ganglioneuroblastoma","High Risk Neuroblastoma"],"enrollment":42,"completionDate":"2026-09-19"},{"nctId":"NCT06081114","phase":"NA","title":"Micronutrient Dose Response Study in Bangladesh","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2023-10-22","conditions":["Micronutrient Status"],"enrollment":643,"completionDate":"2026-09-30"},{"nctId":"NCT06528769","phase":"PHASE2","title":"Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma","status":"RECRUITING","sponsor":"Gabriel Tinoco","startDate":"2025-09-10","conditions":["Leiomyosarcoma","Sarcoma"],"enrollment":16,"completionDate":"2027-12-31"},{"nctId":"NCT06698510","phase":"","title":"Introduction of Arpraziquantel Treatment for Schistosomiasis Control in Preschool-aged Children in Endemic Areas: A Small-scale Public Health Intervention Study","status":"RECRUITING","sponsor":"Peter Steinmann","startDate":"2024-11-25","conditions":["Schistosomiasis"],"enrollment":18500,"completionDate":"2026-03"},{"nctId":"NCT07187505","phase":"NA","title":"Venetoclax Combined With ATRA and ATO in Hyperleukocytic Acute Promyelocytic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Anhui Medical University","startDate":"2025-07-01","conditions":["Acute Promyelocytic Leukemia (APL)"],"enrollment":28,"completionDate":"2027-07-01"},{"nctId":"NCT07006714","phase":"PHASE4","title":"Preoperative Correction of Vitamin D Deficiency in Total Joint Arthroplasty (TJA)","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Miami","startDate":"2025-09-08","conditions":["Osteoarthritis","Vitamin D Deficiency"],"enrollment":200,"completionDate":"2027-07-01"},{"nctId":"NCT06787222","phase":"PHASE2,PHASE3","title":"Effectiveness and Safety of Zingiber Officinale Transdermal Patch for Acne Vulgaris; Study of Interleukin 1 and Skin Microbiome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hasanuddin University","startDate":"2024-11-03","conditions":["Acne Vulgaris"],"enrollment":26,"completionDate":"2025-10-31"},{"nctId":"NCT05438875","phase":"PHASE3","title":"The Combination of ATRA and Eltrombopag as the Treatment of Steroid-resistant/Relapse ITP Based on MSC-C5b-9","status":"COMPLETED","sponsor":"Peking University People's Hospital","startDate":"2022-10-12","conditions":["Purpura, Thrombocytopenic, Idiopathic"],"enrollment":96,"completionDate":"2024-11-30"},{"nctId":"NCT03859687","phase":"PHASE1","title":"Trial of Antibody Responses by Vitamin Supplementation","status":"TERMINATED","sponsor":"St. Jude Children's Research Hospital","startDate":"2019-08-19","conditions":["Healthy Participants"],"enrollment":22,"completionDate":"2025-07-10"},{"nctId":"NCT04305041","phase":"PHASE1,PHASE2","title":"Substudy 02A: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents in Participants With Programmed Cell-death 1 (PD-1) Refractory Melanoma (MK-3475-02A/KEYMAKER-U02)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-06-26","conditions":["Melanoma"],"enrollment":100,"completionDate":"2025-08-25"},{"nctId":"NCT02378246","phase":"NA","title":"Swedish Iodine in Pregnancy and Development in Children (SWIDDICH) Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Göteborg University","startDate":"2012-11","conditions":["Thyroid Gland; Node","Pregnancy","Cognitive Developmental Delay"],"enrollment":1337,"completionDate":"2032-06"},{"nctId":"NCT06641349","phase":"","title":"Effect of Maternal Supplementation From Preconception to Lactation on Child Growth and Development","status":"COMPLETED","sponsor":"University of Toronto","startDate":"2025-01-13","conditions":["Malnutrition","Growth &Amp; Development"],"enrollment":150,"completionDate":"2025-06-04"},{"nctId":"NCT07127653","phase":"NA","title":"Lotion and Toner Bundle 4-Week Lifting Efficacy Study","status":"COMPLETED","sponsor":"ChinaNorm","startDate":"2025-01-23","conditions":["Lifting Efficacy","Facial Aging"],"enrollment":132,"completionDate":"2025-03-31"},{"nctId":"NCT06645041","phase":"NA","title":"The Impact of Vitamin D Supplementation in Hypertensive Vitamin D Deficient Patients.","status":"COMPLETED","sponsor":"University of Sulaimani","startDate":"2024-11-16","conditions":["Hypertension","Vitamin D Deficiency"],"enrollment":60,"completionDate":"2025-08-13"},{"nctId":"NCT07119788","phase":"NA","title":"Investigating the Effects of a Haskap Berry Supplement on Cognitive Health","status":"RECRUITING","sponsor":"University of Reading","startDate":"2025-06-19","conditions":["Cognition"],"enrollment":90,"completionDate":"2026-04"},{"nctId":"NCT06371274","phase":"NA","title":"A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.","status":"RECRUITING","sponsor":"First Affiliated Hospital of Zhejiang University","startDate":"2024-10-10","conditions":["Triple-negative Breast Cancer"],"enrollment":29,"completionDate":"2026-04-30"},{"nctId":"NCT06450925","phase":"PHASE2","title":"Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2025-03-25","conditions":["Graft Vs Host Disease","Vitamin A Deficiency","Vitamin D Deficiency"],"enrollment":190,"completionDate":"2029-08"},{"nctId":"NCT06098846","phase":"NA","title":"Human Transdermal Vitamin D Supplement Study","status":"COMPLETED","sponsor":"King's College London","startDate":"2023-10-23","conditions":["Vitamin D Supplementation"],"enrollment":108,"completionDate":"2024-09-10"},{"nctId":"NCT05682261","phase":"NA","title":"The Effect of Multiple Micronutrient Supplements in Reducing Anemia in Women of Reproductive Age","status":"COMPLETED","sponsor":"Ethiopian Public Health Institute","startDate":"2023-03-23","conditions":["Anemia"],"enrollment":265,"completionDate":"2023-10-17"},{"nctId":"NCT04987073","phase":"NA","title":"Vitamin D Analog in Vitamin D 24-hydroxylase Deficiency","status":"RECRUITING","sponsor":"University Hospital, Caen","startDate":"2022-07-17","conditions":["Idiopathic Infantile Hypercalcemia - Severe Form"],"enrollment":30,"completionDate":"2027-07-01"},{"nctId":"NCT07084116","phase":"PHASE2,PHASE3","title":"Evaluation of Tretinoin Cream on the Integrity of Aged Forearm Skin","status":"ENROLLING_BY_INVITATION","sponsor":"Stanford University","startDate":"2025-07-14","conditions":["Skin Tear","Solar Purpura","Dermatoporosis"],"enrollment":30,"completionDate":"2026-02-01"},{"nctId":"NCT06002269","phase":"NA","title":"A Home-based Lifestyle Intervention for Optimizing Surgical Outcomes Among Urinary Bladder Cancer Patients","status":"COMPLETED","sponsor":"University of Utah","startDate":"2024-06-04","conditions":["Bladder Cancer","Cystectomy","Chemotherapy"],"enrollment":8,"completionDate":"2025-07-08"},{"nctId":"NCT03719092","phase":"NA","title":"High Dose Vitamin A in Preventing Gastrointestinal GVHD in Participants Undergoing Donor Stem Cell Transplant","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2020-02-07","conditions":["Allogeneic Hematopoietic Stem Cell Transplantation Recipient"],"enrollment":62,"completionDate":"2026-12-31"},{"nctId":"NCT03256123","phase":"NA","title":"The Effects of Biscuits Containing Red Palm Oil on School Children With Vitamin A Deficiency in West and East Malaysia","status":"COMPLETED","sponsor":"Malaysia Palm Oil Board","startDate":"2017-04-01","conditions":["Vitamin A Deficiency in Children"],"enrollment":651,"completionDate":"2019-06-30"},{"nctId":"NCT03491267","phase":"EARLY_PHASE1","title":"Study to Determine Effect of Gentle Wounding to Stimulate Hair Follicle Neogenesis","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2018-01-01","conditions":["Central Centrifugal Cicatricial Alopecia (CCCA)"],"enrollment":24,"completionDate":"2024-11-01"},{"nctId":"NCT06880042","phase":"EARLY_PHASE1","title":"COMPARISON OF EFFICACY AND SAFETY OF NARROWBAND UVB WITH 0.1% TACROLIMUS VS NARROWBAND UVB WITH 0.005% CALCIPOTRIOL IN TREATMENT OF VITILIGO","status":"ENROLLING_BY_INVITATION","sponsor":"Dr ayesha wahid","startDate":"2025-05-01","conditions":["Vitiligo - Macular Depigmentation","Tacrolimus"],"enrollment":60,"completionDate":"2025-08-30"},{"nctId":"NCT07029698","phase":"PHASE4","title":"A Study to See if a Combination of Vitamins That is Injected Into a Muscle is as Good and Safe as a Vitamin That is Taken by Mouth","status":"RECRUITING","sponsor":"Medice Arzneimittel Pütter GmbH & Co KG","startDate":"2025-04-16","conditions":["Vitamin B12 Deficiency"],"enrollment":46,"completionDate":"2026-12"},{"nctId":"NCT06658847","phase":"NA","title":"A Study to Evaluate the Effect of a Topical Retinol on Epigenetic Changes and Expression of Certain Genes in the Skin Using Non-invasive Measurements","status":"COMPLETED","sponsor":"Johnson & Johnson Consumer Inc. (J&JCI)","startDate":"2024-11-07","conditions":["Retinoid","Skin Aging","Epigenomics"],"enrollment":66,"completionDate":"2025-04-29"},{"nctId":"NCT00392327","phase":"PHASE3","title":"Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2007-05-23","conditions":["Anaplastic Medulloblastoma","Medulloblastoma"],"enrollment":379,"completionDate":"2028-06-30"},{"nctId":"NCT07017920","phase":"NA","title":"Vitamin D and Hypertensive Disorders of Pregnancy","status":"NOT_YET_RECRUITING","sponsor":"TriHealth Inc.","startDate":"2025-07-01","conditions":["Hypertensive Disorders of Pregnancy"],"enrollment":594,"completionDate":"2027-12-31"},{"nctId":"NCT07012811","phase":"PHASE4","title":"Treatment of Plane Warts With Topical and Oral Retinoids","status":"COMPLETED","sponsor":"Tishreen University","startDate":"2024-02-12","conditions":["Plane Warts"],"enrollment":39,"completionDate":"2025-03-30"},{"nctId":"NCT05324475","phase":"NA","title":"Maintaining Immune and Mitochondrial Functions in Old Adults With SAfe Nutrition.","status":"RECRUITING","sponsor":"Patrizia D'Amelio","startDate":"2025-04-01","conditions":["Malnutrition","Sarcopenia"],"enrollment":240,"completionDate":"2028-03-30"},{"nctId":"NCT03031249","phase":"PHASE1,PHASE2","title":"Efficacy and Safety of ATO Plus ATRA in Nucleophosmin-1 Mutated Acute Myeloid Leukemia","status":"ENROLLING_BY_INVITATION","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2017-02-08","conditions":["AML"],"enrollment":80,"completionDate":"2027-10-15"},{"nctId":"NCT05999812","phase":"PHASE2","title":"Clinical Trial of All-trans-retinoic Acid, Bevacizumab and Atezolizumab in Colorectal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2023-12-19","conditions":["Colorectal Cancer"],"enrollment":22,"completionDate":"2028-10-01"},{"nctId":"NCT06989879","phase":"","title":"Knowledge of Students About Vitamin A and Assessment of Eye Manifestations in Quranic Schools (Khalwai) Khartoum State, Sudan 2022","status":"COMPLETED","sponsor":"University of Khartoum","startDate":"2022-11-01","conditions":["Vitamin A Deficiency","Night Blindness"],"enrollment":332,"completionDate":"2023-01-01"},{"nctId":"NCT05362929","phase":"NA","title":"Efficacy and Tolerability of a Hybrid Fractional Laser for the Treatment of Acne Scars in Patients With Skin of Color","status":"RECRUITING","sponsor":"Albert Einstein College of Medicine","startDate":"2023-10-11","conditions":["Acne Scars - Mixed Atrophic and Hypertrophic","Hyperpigmentation","Laser-Induced Hyperpigmentation"],"enrollment":46,"completionDate":"2026-09"},{"nctId":"NCT05366933","phase":"PHASE1","title":"B-Complex: A Nutraceutical SANS Countermeasure","status":"RECRUITING","sponsor":"National Aeronautics and Space Administration (NASA)","startDate":"2022-08-01","conditions":["Optic Disc Edema","Endothelial Dysfunction"],"enrollment":16,"completionDate":"2032-09-30"},{"nctId":"NCT05259722","phase":"PHASE3","title":"A 24 Week Trial to Compare the Efficacy and Safety of Delgocitinib Cream 20 mg/g Twice-daily With Alitretinoin Capsules Once-daily in Adult Participants With Severe Chronic Hand Eczema","status":"COMPLETED","sponsor":"LEO Pharma","startDate":"2022-06-15","conditions":["Chronic Hand Eczema"],"enrollment":513,"completionDate":"2023-12-05"},{"nctId":"NCT02402660","phase":"PHASE2","title":"Phase 2 Tolerability and Effects of ALK-001 on Stargardt Disease","status":"ENROLLING_BY_INVITATION","sponsor":"Alkeus Pharmaceuticals, Inc.","startDate":"2015-08","conditions":["Stargardt Disease","Stargardt Macular Degeneration","Stargardt Macular Dystrophy","Autosomal Recessive Stargardt Disease 1 (ABCA4-related)"],"enrollment":160,"completionDate":"2026-11-30"},{"nctId":"NCT04239625","phase":"PHASE2","title":"Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alkeus Pharmaceuticals, Inc.","startDate":"2019-12-20","conditions":["Stargardt Disease","Stargardt Macular Degeneration","Stargardt Macular Dystrophy","Autosomal Recessive Stargardt Disease 1 (ABCA4-related)"],"enrollment":200,"completionDate":"2026-12"},{"nctId":"NCT02230228","phase":"PHASE1","title":"Phase 1 Safety Study of ALK-001 in Healthy Volunteers","status":"COMPLETED","sponsor":"Alkeus Pharmaceuticals, Inc.","startDate":"2014-04","conditions":["Stargardt Disease","Age-related Macular Degeneration","Other Retinal Dystrophies"],"enrollment":40,"completionDate":"2015-02"},{"nctId":"NCT06937424","phase":"NA","title":"Post-endodontic Access Cavity Cleaning Techniques","status":"COMPLETED","sponsor":"Marmara University","startDate":"2024-08-19","conditions":["Teeth With Root Canal Treatment"],"enrollment":70,"completionDate":"2025-04-07"},{"nctId":"NCT03478878","phase":"EARLY_PHASE1","title":"Vitamin A Palmitate Supplementation in Patients With Reticular Pseudodrusen (RPD) and Delayed Dark Adaptation","status":"COMPLETED","sponsor":"National Eye Institute (NEI)","startDate":"2018-05-14","conditions":["Reticular Pseudodrusen (RPD)","Age-Related Macular Degeneration"],"enrollment":9,"completionDate":"2022-06-17"},{"nctId":"NCT03478865","phase":"EARLY_PHASE1","title":"Vitamin A Palmitate Supplementation in People With Age-Related Macular Degeneration (and Without Reticular Pseudodrusen) and Delayed Dark Adaptation","status":"COMPLETED","sponsor":"National Eye Institute (NEI)","startDate":"2018-04-20","conditions":["AMD"],"enrollment":8,"completionDate":"2023-06-16"},{"nctId":"NCT06536413","phase":"PHASE1,PHASE2","title":"ATRA and Carfilzomib in Plasma Cell Myeloma Patients","status":"RECRUITING","sponsor":"The Methodist Hospital Research Institute","startDate":"2024-07-29","conditions":["Multiple Myeloma"],"enrollment":42,"completionDate":"2030-07"},{"nctId":"NCT05879406","phase":"NA","title":"A Study to Evaluate the Efficacy and Safety of Clear Skin Formula on Mitigating Mild to Moderate Non-cystic Acne","status":"COMPLETED","sponsor":"Ablon Skin Institute Research Center","startDate":"2023-05-31","conditions":["Non-Cystic Acne"],"enrollment":40,"completionDate":"2024-01-23"},{"nctId":"NCT06759493","phase":"","title":"Validation and Simplification of the Retinol Isotope Dilution Technique in Burkinabe Schoolchildren","status":"RECRUITING","sponsor":"Institut de Recherche en Sciences de la Sante, Burkina Faso","startDate":"2024-11-21","conditions":["Vitamin A Deficiency","Inflammation"],"enrollment":158,"completionDate":"2025-06-30"},{"nctId":"NCT06875050","phase":"NA","title":"Antioxidant Supplements in Cystic Fibrosis Children","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2024-03-12","conditions":["Cystic Fibrosis (CF)"],"enrollment":60,"completionDate":"2025-03-01"},{"nctId":"NCT04716712","phase":"PHASE4","title":"Infant Mortality Reduction by the Mass Administration of Azithromycin","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2021-10-04","conditions":["Child Mortality"],"enrollment":694400,"completionDate":"2026-01-30"},{"nctId":"NCT02688140","phase":"PHASE3","title":"Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia","status":"COMPLETED","sponsor":"Technische Universität Dresden","startDate":"2016-06","conditions":["Acute Promyelocytic Leukemia"],"enrollment":135,"completionDate":"2025-01-20"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"route":"Topical","formulation":"Capsule, Cloth, Cream, Patch","formulations":[{"form":"CAPSULE","route":"ORAL","productName":"Vitafol Caplet"},{"form":"CAPSULE","route":"ORAL","productName":"Prenara"},{"form":"CAPSULE, GELATIN COATED","route":"ORAL","productName":"Dermamed Nutrition for troubled skin"},{"form":"CAPSULE, GELATIN COATED","route":"ORAL","productName":"Reaphirm Plant Source DHA"},{"form":"CAPSULE, GELATIN COATED","route":"ORAL","productName":"VitafolOne"},{"form":"CAPSULE, LIQUID FILLED","route":"ORAL","productName":"Vitafol Plus"},{"form":"CLOTH","route":"TOPICAL","productName":"SKINEEZ"},{"form":"CREAM","route":"TOPICAL","productName":"Budpak Vitamin A and D"},{"form":"CREAM","route":"TOPICAL","productName":"Vitamin A and D"},{"form":"PATCH","route":"TOPICAL","productName":"C-Mask Pack"},{"form":"SOLUTION","route":"ORAL","productName":"Multi-Vitamin Fluoride Drops"},{"form":"SOLUTION","route":"ORAL","productName":"Tri-Vite Drops with Fluoride"},{"form":"TABLET","route":"ORAL","productName":"O-Cal Prenatal Vitamin"},{"form":"TABLET","route":"ORAL","productName":"Strovite One Caplets"},{"form":"TABLET","route":"ORAL","productName":"PreNatal Vitamins Plus"}]},"crossReferences":{"NUI":"N0000148615","MMSL":"232172","NDDF":"001000","UNII":"G2SH0XKK91","VUID":"4021164","CHEBI":"CHEBI:50211","VANDF":"4017648","INN_ID":"2243","RXNORM":"11246","UMLSCUI":"C0042839","chemblId":"CHEMBL986","ChEMBL_ID":"CHEMBL986","KEGG_DRUG":"D06543","DRUGBANK_ID":"DB00162","PDB_CHEM_ID":" RTL","PUBCHEM_CID":"445354","SNOMEDCT_US":"82156005","IUPHAR_LIGAND_ID":"4053","SECONDARY_CAS_RN":"11103-57-4","MESH_DESCRIPTOR_UI":"D014801"},"formularyStatus":[],"_enricherVersion":"v2","_offLabelChecked":true,"developmentCodes":[],"ownershipHistory":[{"period":"1953-","companyName":"Pfizer","relationship":"Original Developer"}],"publicationCount":16688,"therapeuticAreas":["Immunology"],"atcClassification":{"source":"DrugCentral","atcCode":"A11CA01","allCodes":["A11CA01","D10AD02","R01AX02","S01XA02"]},"biosimilarFilings":[],"originalDeveloper":"Hospira","recentPublications":[{"date":"2026 Mar 24","pmid":"41904900","title":"Unveiling Colorectal Cancer Cell Heterogeneity: Identification of Biomarkers and Disease-driving Cell Subpopulations through Scissor and CIBERSORTx on Integrated Transcriptomic Profiling.","journal":"Computational biology and chemistry"},{"date":"2026 Mar 25","pmid":"41904678","title":"Loss of function of retinol dehydrogenase 11 causes a recessive syndrome characterized by myopathy, retinal dystrophy, juvenile cataracts, and microcephaly.","journal":"Genetics in medicine : official journal of the American College of Medical Genetics"},{"date":"2026 Feb 27","pmid":"41901225","title":"Rosemary Aqueous Extract as a Natural Alternative to Retinol for Skin Aging Intervention.","journal":"Pharmaceuticals (Basel, Switzerland)"},{"date":"2026","pmid":"41889417","title":"Riboflavin (VB2) inhibits hepatocellular carcinogenesis by enhancing retinol metabolism and suppressing cell proliferation in Hras12V transgenic mice.","journal":"Frontiers in oncology"},{"date":"2026 Mar 25","pmid":"41881058","title":"Association of Salivary Asprosin and RBP4 Levels in Periodontitis Patients with Varying Waist-to-Height Ratios: A Case-Control Study.","journal":"European journal of dentistry"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"approved","companyName":"Pfizer","companyId":"pfizer","modality":"Small molecule","firstApprovalDate":"1953","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1953-02-20T00:00:00.000Z","mah":"HOSPIRA","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":2,"lastValidatedAt":"2026-04-20T03:30:45.366487+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}